Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer

Background: Oncolytic viral therapy is a new strategy for tumor eradication which combines the advantages of viral therapy and gene therapy. Silencing SATB1 exhibits strong inhibitory effect on the growth of prostate cancer. Docetaxel (DTX) is the gold standard for chemotherapy of prostate cancer, b...

Full description

Saved in:
Bibliographic Details
Published in:J Cancer
Main Authors: Mao, Lijun, Yu, Haiyuan, Ma, Sai, Xu, Ziyang, Wei, Fukun, Yang, Chunhua, Zheng, Junnian
Format: Artigo
Language:Inglês
Published: Ivyspring International Publisher 2021
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7890306/
https://ncbi.nlm.nih.gov/pubmed/33613773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.46868
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items